Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.37 |
| ▸ | F10 | P00742 | 3/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17358236 | 1.00 | STING1 (0.42) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL17358246 | 1.00 | STING1 (0.42) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL16016989 | 0.92 | PDE4A (0.42) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL18427309 | 0.88 | STING1 (0.46) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5267159 | 0.88 | STING1 (0.46) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL18427349 | 0.88 | STING1 (0.46) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL16016991 | 0.87 | ALDH1A1 (0.55) | STING1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL15450266 | 0.86 | CYP3A4 (0.44) | PDE4APDE4BPDE4CPDE4DMAPT | |
| SCHEMBL15450257 | 0.86 | CYP3A4 (0.44) | PDE4APDE4BPDE4CPDE4DMAPT | |
| SCHEMBL16016915 | 0.86 | CYP3A4 (0.44) | PDE4APDE4BPDE4CPDE4DMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9556140-B2 | Approach for synthesis of catechins | SPHAERA PHARMA PVT. LTD. (IN) | 2017-01-31 | — | — | US | disclosed |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC. | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | NQO1, COMT, NNMT | STING1 4823/4885PDE4A 3768/4885PDE4B 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.